To the best of our knowledge, this study is the first to demonstrate the tumor-promoting effects of 3MC in inducing RCC phenotypes through HIF1α-associated RhoA downregulation in vitro and in vivo. The gene discussed is HIF1A; the disease is renal cell carcinoma.